Reading Vital Signs: Pharmaceuticals, the Market’s Trusted Antidote

Bonus

Among listed pharma companies, average returns have crossed 20 per cent in the last few months, except for Cipla.

4 minutes of reading Last updated: August 04, 2024 | 23:46 IST

Amid valuation concerns, investors are playing it safe and turning to defensive sectors. The pharmaceutical sector benefited from this shift, attracting investors looking for steady cash flows. On Friday, while most sectoral indices closed lower, the pharma index was the only one to end the day higher.

Over the past month, the Nifty Pharma stock index has outperformed other sector indices with a 7 per cent gain, while the Nifty 50 index has returned a maximum of 1.6 per cent.

Over the past three months, the pharmaceutical index recorded the second-highest increase, rising 14 points.

First published: August 04, 2024 | 23:46 IST